Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg). [PDF]
Chang K +6 more
europepmc +1 more source
Hemoadsorption for refractory shock after amlodipine intoxication: a case report. [PDF]
Boavida L +4 more
europepmc +1 more source
Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial. [PDF]
Ahn HS +33 more
europepmc +1 more source
Maurizio Destro1, Francesca Cagnoni1, Antonio D’Ospina1, Alessandra Rossi Ricci1, Elena Demichele1, Emmanouil Peros1, Augusto Zaninelli2, Paola Preti31Internal Medicine, Ospedale Unificato Broni-Stradella, Stradella (PV), Italy; 2General ...
et al +3 more
core
Identification of efflux inhibitors through a drug repurposing strategy in <i>Candida albicans</i>. [PDF]
Marques D, Costa SS, Rodrigues L.
europepmc +1 more source
Left Ventricular Unloading During Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) in Toxic Shock: Successful ECpella Support After Massive Amlodipine Ingestion. [PDF]
Sharma M +4 more
europepmc +1 more source
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study. [PDF]
Kim SY, Kwak YG, Kim MG, Moon SJ.
europepmc +1 more source
Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial. [PDF]
Youn JC +13 more
europepmc +1 more source
Signal Detection of Adverse Events Associated with Four Dihydropyridine Calcium Channel Blockers Based on the FAERS Database. [PDF]
Guo Z +5 more
europepmc +1 more source

